Advances in Study on Novel Oral Biological Agents in Treatment of Inflammatory Bowel Disease / 胃肠病学
Chinese Journal of Gastroenterology
; (12): 498-501, 2017.
Article
en Zh
| WPRIM
| ID: wpr-610680
Biblioteca responsable:
WPRO
ABSTRACT
As a new therapy in past twenty years,biological agents have been approved for the treatment of inflammatory bowel disease (IBD). However,biological agents currently used for IBD treatment require intravenous or subcutaneous injections,and some require infusion under close observation. Therefore,it is of positive clinical significance to find a safe and effective oral biological agent. This article reviewed recent advances in study on novel oral biological agents in the treatment of IBD.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Gastroenterology
Año:
2017
Tipo del documento:
Article